Marrone Bio Innovations prices upsized IPO at $12, below the range

A generic image of a calculator and a pen Credit: Shutterstock photo

Marrone Bio Innovations, a producer of bio-based pest management and plant health products, raised $57 million by offering 4.8 million shares (550,000 more than expected) at $12, below the range of $14 to $17. The proceeds raised were 12% lower than expected. The company commands a market value of $226 million and an enterprise value of approximately $178 million. Marrone Bio Innovations will list on the NASDAQ under the symbol MBII. Jefferies & Co. and Piper Jaffray acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.